Sickle cell disease-related organ damage occurs irrespective of pain rate: Implications for clinical practice

Haematologica

Volumn 93, Issue 5, 2008, Pages 757-760

  Van Beers, Eduard J ^a   Van Tuijn, Charlotte F J ^a   Mac Gillavry, Melvin R ^b   Van Der Giessen, Anna ^a   Schnog, John John B ^b   Biemond, Bart J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Organ damage; Pain rate; Sickle cell disease; Systematic screening

Indexed keywords

ADULT; ARTICLE; AVASCULAR NECROSIS; CHOLELITHIASIS; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROALBUMINURIA; ORGAN INJURY; PAIN ASSESSMENT; PREVALENCE; PRIAPISM; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA;

ADULT; ALBUMINS; ANEMIA, SICKLE CELL; COMORBIDITY; CREATININE; FEMALE; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; IRON OVERLOAD; MALE; OSTEONECROSIS; PAIN; PAIN MEASUREMENT; THALASSEMIA;

EID: 43449108586     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12152     Document Type: Article

References (25)

1. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007;21:37-47.
2. Schnog JJ, Lard LR, Rojer RA, van der Dijs FP, Muskiet FA, Duits AJ. New concepts in assessing sickle cell disease severity. Am J Hematol 1998;58:61-6.
3. Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J, et al. Causes of death in sickle cell disease: an autopsy study. Br J Haematol 2003;123:359-65.
4. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-6.
5. Bakker AJ. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 1999;22:307-13.
6. Morgan AG, Serjeant GR. Renal function in patients over 40 with homozygous sickle-cell disease. Br Med J (Clin Res Ed) 1981;282:1181-3.
7. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease - life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
8. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease. N Engl J Med 2004;350:886-95.
9. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-82.
10. MacDonald CB, Bauer PW, Cox LC, McMahon L. Otologic findings in a pediatric cohort with sickle cell disease. International Journal of Pediatric Otorhinolaryngology 1999;47:23-8.
11. Files B, Brambilla D, Kutlar A, Miller S, Vichinsky E, Wang W, et al. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol 2002;24:284-90.
12. Stuart MJ, Setty BNY. Sickle Cell Acute Chest Syndrome: Pathogenesis and Rationale for Treatment. Blood 1999;94:1555-60.
13. Ou CN, Rognerud CL. Rapid analysis of hemoglobin variants by cation-exchange HPLC. Clin Chem 1993;39:820-4.
14. Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alpha-thalassemia. Blood 2001;98:250-1.
15. Schnog JB, Duits AJ, Muskiet FA, ten CH, Rojer RA, Brandjes DP. Sickle cell disease; a general overview. Neth J Med 2004;62:364-74.
16. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 2005;84:363-76.
17. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-9.
18. Fowler JE, Jr., Koshy M, Strub M, Chinn SK. Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol 1991;145:65-8.
19. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.
20. Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, et al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 1991;115:614-20.
21. Walker TM, Hambleton IR, Serjeant GR. Gallstones in sickle cell disease: observations from The Jamaican Cohort study. J Pediatr 2000;136:80-5.
22. Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991;325:1476-81.
23. Koshy M, Entsuah R, Koranda A, Kraus AP, Johnson R, Bellvue R, et al. Leg ulcers in patients with sickle cell disease. Blood 1989;74:1403-8.
24. Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol 2000;63:205-11.
25. Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant GR, Bird AC. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology 2005;112:1869-75.